Visualitza per autor "Quintana, Ester"
Ara mostrant els elements 1-4 d 4
-
Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis
Coll-Martinez, Clàudia; Quintana, Ester; Salavedra Pont, Judit; Buxó, Maria; González del Rio, Marina; Gómez Aguilar, Immaculada; Muñoz San Martín, María; Álvarez Bravo, Gary; Robles-Cedeño, René; Ramió-Torrentà, Lluís; Gich, Jordi; Villar, Luisa M (Wiley, 2021-12) -
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis
Picón, Carmen; Tejeda-Velarde, Amalia; Fernández-Velasco, José Ignacio; Álvarez-Lafuente, Roberto; Quintana, Ester; Matute Blanch, Clara; Espejo Ruiz, Carmen; Comabella Lopez, Manuel (Frontiers Media, 2021-07) -
Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab
Walo-Delgado, Paulette Esperanza; Medina, Silvia; Quintana, Ester; Fernández-Velasco, José Ignacio; Montalban Gairín, Xavier; Midaglia Fernandez, Luciana; Sainz de la Maza, Susana; Comabella Lopez, Manuel; Monreal, Enric (Frontiers Media, 2021-10) -
Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
Aliaga-Gaspar, Pablo; Hurtado Guerrero, Isaac; Ciano-Petersen, Nicolás Lundahl; Urbaneja, Patricia; Brichette-Mieg, I.; Reyes, Virginia; Quintana, Ester; Ramió-Torrentà, Lluís (Frontiers Media, 2021-12-16)